Global cases of dementia currently stand at 50 million people per year, a number the World Health Organisation predicts will triple by 2050 . It’s a disease that has enormous impact on the individual wellbeing of the patient and the family surrounding them and is often a slow, distressing degeneration. After seeing the positive results of CBD in the treatment of a number of mental health and physical wellness complaints, CBD’s experimental use for dementia treatment has a growing number of advocates with more and more studies being conducted around the use of CBD and dementia. The upside is that there is excellent initial evidence to support significant improvements in behaviour and body rigidity when CBD has been administered to those suffering severe dementia. CBD is much safer than many of the chemical alternatives used in treating the disease and has little to no side effects too. Doctors are clear that we need to do more to help people manage this increasingly prevalent disease.
CBD
Dementia Patients Could Benefit from CBD
December 18, 20201 min read
Tags:CBDWellnessScience
Share:
BR
Written by BioMuti Research Team
The BioMuti editorial team combines expertise in biochemistry, herbal medicine, and African ethnobotany to bring you science-backed wellness insights.
Related Articles

CBD
South Africa's Cannabis Opportunity: Serving Local Wellness Needs First
As South Africa's cannabis industry develops, the focus must be on building local value chains that serve domestic wellness needs. Explore the science behind CBD, the regulatory landscape, and how Bio…
June 19, 2026|4 min read

CBD
The Complete Guide to BioMuti Peptides: BPC-157, TB-500, GHK-Cu & More
Your complete guide to BioMuti's full peptide range in South Africa. From BPC-157 and TB-500 to GHK-Cu, NAD+, MOTS-c, and more — explore, compare, and buy.
May 25, 2026|8 min read

CBD
BPC-157 for Recovery: How It Works & Where to Buy in South Africa
Discover how BPC-157 accelerates injury recovery — how it works, protocols, stacking options, and where to buy research-grade BPC-157 in South Africa from BioMuti.
May 25, 2026|5 min read